The IMC team is committed to combining artificial intelligence and immune biotechnology for the development of antibody drugs,
hoping to improve the quality of health and extend active lifespans of humans.
Our team possesses core technologies in big data analysis, artificial intelligence prediction,
computer-aided drug design, and next-generation gene sequencing.

3.9
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Closed 9 months, 3 weeks ago

Pre-Sale 12/20/2017 noon - 12/31/2017 midnight
Token Sale 01/01/2018 noon - 01/20/2018 midnight
Country Unspecified
Y
Yu-Mu Chen
CHIEF EXECUTIVE OFFICER
S
Shun-Yu Jhong
CHIEF OPERATING OFFICER
K
Keng-Ming Lee
CHIEF TECHNOLOGY OFFICER
P
Pin-Cheng Chiu
CHIEF INFORMATION OFFICER
P
Penny Chiu
TRANSLATOR
D
Dr. Wei-Cheng Lo
CHIEF RESEARCH CONSULTANT
3.9
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Closed 9 months, 3 weeks ago

Pre-Sale 12/20/2017 noon - 12/31/2017 midnight
Token Sale 01/01/2018 noon - 01/20/2018 midnight
Country Unspecified

Financial information

Platform Ethereum

Interest

Alexa rank 15,278,764 th
Telegram participants 7
Twitter followers 11
Promotional video views 164
Similar icos
Disclaimer

TrackICO does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on TrackICO is meant to be used for information purposes only, and should not be taken as financial or investment advice.